Pay in 4 interest-free payments of $66.12 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
This photosensitizing agent has shown to induce apoptosis and necrosis in cancer cells during photodynamic therapy
a refinement of the traditional TCA method
cell cycle analysis
inflammatory bowel disease
FGF-2 regulates immune processes by specifically targeting tyrosine kinase receptors and activating the FGF/FGFR signaling pathway
Tirzepatide Pack Size:5 mg This photosensitizing agent has shownTirzepatide is a novel dual glucose dependent insulinotropic polypeptide (GIP) and glucagon like peptide 1 (GLP 1) receptor agonist. Tirzepatide potently activates the GLP 1R signaling pathway to stimulate glucose dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP 1R. Tirzepatide is a synthetic peptide with glucose lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and